Status:
UNKNOWN
Natural History of COVID-19-Related Atrial Fibrillation
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
COVID-19
Atrial Fibrillation New Onset
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The unCOVer-AF prospective, multicenter registry aims at determining the natural history of atrial fibrillation (AF) via continuous cardiac rhythm monitoring in patients with a first arrhythmic episod...
Detailed Description
Coronavirus Disease 2019 (COVID-19) is a novel coronavirus strain disease, which has rapidly spread worldwide with more than 100 million confirmed cases to date. COVID-19 is mainly characterized by re...
Eligibility Criteria
Inclusion
- Age\> 18 years;
- Confirmed infection with SARS-CoV-2;
- Patients with a first clinical episode of AF ≥30 s at admission or during hospitalization for COVID-19;
- Patients with:
- implantation of an ILR, a PMK, or an ICD during COVID-19 hospitalization or within 30 days after hospital discharge, or
- an ILR, a PMK, or an ICD implanted before COVID-19 hospitalization.
Exclusion
- History of AF or flutter irrespective of type;
- Moderate/severe mitral stenosis;
- Mechanical prosthetic heart valve(s);
- Kidney failure treated with permanent dialysis;
- Any condition (e.g. psychiatric illness, dementia) or situation, that in the investigators opinion could put the subject at significant risk, confound the study results, or interfere significantly with the subject participation in the study;
- Unwillingness to participate.
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04830774
Start Date
April 15 2021
End Date
December 31 2023
Last Update
November 23 2021
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas City Heart Rhythm Institute, Overland Park
Kansas City, Kansas, United States, 66211
2
Texas Cardiac Arrhythmia Institute
Austin, Texas, United States, 78723
3
Vrije Universiteit Brussel
Brussels, Belgium
4
Department of Cardiovascular/Respiratory Diseases, Nephrology, Anesthesiology, and Geriatric Sciences, Policlinico Umberto I, Sapienza University of Rome
Rome, Lazio, Italy